XLTA®, a super absorbent, hydrocapillary, non-adherent wound dressing made from predominantly natural fibers, today announced a strategic distributor partnership with Total Ancillary, a Texas-based healthcare distribution company recognized as a trusted influencer in the wound care space.
Headsafe, an emerging Australian medical technology company, today announced its strategic entry into the U.S. healthcare market with the launch of Nurochek™—a lightweight, portable, FDA-cleared brain assessment system engineered to enhance concussion evaluation in clinical settings through proprietary AI and machine learning (ML) technology.
Autocam Medical, a global leader in precision-machined medical devices, announces plans to construct a 100,000 SF state-of-the-art manufacturing facility in Warsaw, Indiana.
Founded in 1986, still founder-led, and built on long-term manufacturing partnerships, direct surgeon relationships, and service that shows up under pressure
EXALTA Group, a global leader in the development and manufacturing of integrated OEM solutions for mission-critical medical devices, today announced it has obtained European Medical Device Regulation (EU-MDR) certification for its full range of headed and headless titanium compression screws used in trauma and reconstructive surgery.
Why Europe’s shifting regulatory landscape, global trade tensions, and startup survival strategies matter more than ever.
At The MedTech Digest, we believe in spotlighting the founders and technologies shaping the future of
healthcare. Our team at MedTech Momentum is honored to support XLTA as you bring XLTA®
Hydrocapillary Triple-Action™ technology to the U.S. market.
Some of the most innovative leaders in the Medical Technology industry don’t arrive there through a straight line, and that’s certainly the case with Brian Kieser. Before founding Nvision Biomedical Technologies and building one of the most integrated innovation ecosystems in the industry, Brian was a mechanical engineering student, then an accountant, and eventually a certified public accountant (CPA) at KPMG. From technical schematics to financial audits, he’s seen every layer of how a business is built successfully.
We sit down with Brian More, CEO of Nanovis, for a candid conversation on strategy, science, and scaling up smart. From startup grit to a groundbreaking collaboration with Medtronic, Brian shares how Nanovis is transforming orthopedic and spinal implants through surface-level innovation, and why staying focused is the key to long-term success.
Founded as a spin-out from the University of Oxford, Brainomix has already transformed stroke care across Europe. With more than 70% market share in the UK and over 60 peer-reviewed publications validating its efficacy in real world settings, the company has delivered what few others can: evidence-based, scalable AI that improves outcomes and makes stroke systems more efficient.
